Latin American Journal of Pharmacy



 
 
 Vol. 34 Nº 3
Lat. Am. J. Pharm. 34 (3): 425-636 (2015)  

SUMMARIES OF ARTICLES (to see the full articles enter you username and password)

REGULAR ARTICLES
 
Design and Optimization of Controlled Release Ketoprofen Tablets  *
ZAFAR F., SHOAIB M.H., ALI H. & ALAM Z.M.  (429)
 
 
Pharmacobotanical Characters of Mikania micrantha (Asteraceae) and its Support for Quality Control  *
ARAUJO F.F., AMORIN M., dos SANTOS V.L.P., FRANCO C.R.C., FOLQUITTO D.G., da SILVA R.Z., FARAGO P.V., TAKEDA I.J.M., NAKASHIMA T. & BUDEL J.M.  (437)
 
 
Determination of Terbinafine and its Main Metabolite in Rat Plasma by UPLC-MS/MS: Application to a Pharmacokinetic Study  *
ZHOU Y., WANG S., GENG P., PAN P., WEI M., HU G. & LU X.  (443)
 
 
HPLC Method for Simultaneous Determination of Entecavir and Tenofovir in Human Spiked Plasma and Pharmaceutical Dosage Forms  *
ALTAF H., ASHRAF M., HAYAT M.M., HUSSAIN A., ALI Y., SHAHZAD N., AHMAD M.B., RAHMAN J., AKHTAR N., & REHMAN S.  (449)
 
 
Development and Validation of an HPLC Method for the Quantification of Sitagliptin in Plasma and Tablet Dosage Form  *
ASHRAF M., SHAHZAD M.N., HAYAT M.M., RAHMAN J., EJAZ S., ALTAF H. & NASIM F.H.  (456)
 
 
Pharmacokinetic Study of Icariin in Rat by UPLC-MS/MS  *
WU C., WANG S., GENG P., SHEN H., HAN A. & ZHOU Y.  (462)
 
 
Neutralizing Ability of Bioactive Glass (BG) on the PLGA Microsphere Degradation  *
CAO J., SHI S., GENG H., DONG Y., JI L., XU Y. & LIU H.  (468)
 
 
A New Anti-Inflammatory Triterpenoid Saponin from Penthorum chinense Pursh  *
WANG Y., WANG Y., LIU B., YUAN L., CHEN J., BAO J. & GUO M.  (474)
 
 
An Investigation of the Off-Label Use of Bevacizumab  *
LIU T., CHEN Z., LIN Z., CHEN F. & HUANG H.  (480)
 
 
Taste-Masked Spray Dried Microparticles for Intra-Oral Dispersible Tablets of Lornoxicam  *
SHAZLY G.A., IBRAHIM M.A., AUDA S.H., EL-BADRY M., AL-SUWAYEH S.A. & SHAKEEL F.  (488)
 
 
Design, Evaluation and Optimization by Central Composite Design of Effervescent Floating Tablets of Norfloxacin Using Natural Polymers  *
ASHGAR A., SETHI A., HANIF M., SHARIF K., AKHTAR N., CHOWDHARY F., MASUUD M.I. & AWAN M.A.B.  (496)
 
 
A Simple HPLC Method for Determining Enoxacin in Human Plasma and Application to a Pharmacokinetic Study  *
LV S., WANG X., ZHANG X., LI H., WANG B., & ZHANG D.  (508)
 
 
Parameter Optimization and Process Control for the Sterilization of Ornidazole and Sodium Chloride Injection  *
YANG Q., MAO K., XIE Z-K., WEI L-H., DENG B., PAN H-C. & LIU H.  (513)
 
 
Role of Linalool in Enantioselective Permeation of Naproxen across Excised Rat Skin  *
YU W., ZHANG L., RONG Y., GUO X., & YE J.  (522)
 
 
Characterization and Antimicrobial Activity of Novel Hazelnut Oil Microemulsion Loaded with Mitomycin C  *
KOTMAKÇI M., ÖZTÜRK İ, KANTARCI G. & ERMERTCAN Ş.  (529)
 
 
The Molecular Mechanism Involved in the Protective Effect of Etodolac Against Ovarian Injury Induced with Ischemia/Reperfusion in Rats  *
AL R.A., YAPCA O.E., DOGAN H., MAMMADOV R., ALTUNER D., SULEYMAN B. & CETIN N.  (537)
 
 
Development of a LC-MS/MS Method for the Determination of Dasatinib in Rat Plasma  *
CAO S., WANG X., ZHENG L., SUN M., WANG Y. & FAN R.  (542)
 
 
Pharmacokinetic Study of Remifentanil in Rat Plasma by LC–MS/MS  *
CHEN S., ZHANG X., WANG G., ZHANG Y., LIU J., TIAN J., & HU J.  (547)
 
 
Effect of Insoluble Excipients on Performance of Direct Compression Controlled Release Matrices  *
LAGUNA-LÓPEZ S., ANGULO-DELGADO C.R. & VILLAFUERTE-ROBLES L.  (552)
 
 
Method Development and Validation for Simultaneous Determination of Levofloxacin and Diclofenac Sodium in Pharmaceutical Dosage Form  *
FAYYAZ M., YOUSUF R.I., SHOAIB M.H., ALI T., HAIDER S., BUSHRA R., ASHRAF N. & HASSAN S.  (562)
 
 
Skin Lightening and Sebum Control Efficacy of a Cosmetic Emulsion Containing Extract of Tamarind Seeds on Asian Skin Type  *
WAQAS M.K., AKHTAR N., BAKHSH S., CALDEIRA E.J. & KHAN B.A.  (570)
 
 
The Effect of Incorporating Gossypol into L-Ascorbyl Palmitate Coagel on Rheological and Viscoelastic Properties  *
OKOAMPAH A. & TANG L.  (576)
 


SHORT COMMUNICATIONS
 
High Performance Liquid Chromatographic Determination of C66, a New Curcumin Derviative, in Rat Plasma and its Pharmacokinetic Studies  *
XU X., JIANG H., YU Y., HU G., GE R. & CAI Y.  (585)
 
 
Metabolomics-Based Elucidation of Therapeutic Mechanism of Luteolin Towards Autism in Children and Relevant Drug-Drug Interaction Risk  *
SUN X., LI C., WANG X., ZHANG R. & HONG Z.  (590)
 
 
Effect of Vera Pammy on Early Healing Strength after Peripheral Nerve Injury Repair  *
WU X., HUANG Q., ZHENG H., TIAN J., ZHOU P. & LIU Z.  (593)
 
 
Pharmaceutical Services in Family Health Support Team: the Brazilian Experience  *
NAKAMURA C.A. & LEITE S.N.  (598)
 
 
Synthesis and Antibacterial Activities of Two Novel Pyran Annulated Heterocyclic Compounds  *
TAN H., ZHANG Y. & WANG R.  (602)
 
 
Determination and Pharmacokinetic Study of Levofloxacin in Human Plasma by HPLC  *
PAN C., ZHUGE L., JIN L., WANG Y., ZHOU G., LIN W., ZHANG Q. & CHEN W.  (605)
 
 
Chirality Influence Towards Rivaroxaban-Zidovudine Interaction  *
WANG W., LI Y., XIE Z., & XU D.  (610)
 
 
Drug-Drug Interaction between (S)-Rivaroxaban and Orthopedics Treatment Drugs Mainly Undergoing CYP3A4 Metabolism  *
SHI J. & GUO Y.  (613)
 
 
The Utilization Risk of Rivaroxaban in the Anti-Glioma Therapy Regimen  *
ZHANG H., LIU H., XU F., & ZHANG B.  (616)
 
 
Development of Maple Syrup Urine Disease (MSUD) Therapy Drug for Autism Patients and Safety Evaluation  *
SUN X., HU J., QI H., ZHANG R. & HONG Z.  (619)
 
 
Quantification of Lorazepam in Human Plasma Using HPLC: Application to a Pharmacokinetic Study  *
FENG J., SHEN R., ZHANG D., DONG Z., ZHANG D., & WANG H.  (622)
 
 
The Risk of Flavonoids Utilization in the Anti-Tumor Therapy  *
YU M., GUO Y., WANG J., WANG C., WANG A., ZHANG X., TU Y. & BAI M.  (627)
 
 
Risk Evaluation of Rivaroxaban in the Application of Propofol in Anaesthesia  *
KANG Z., YU J., YU H., JIANG Y., CAO Q., & HAN J.  (631)
 



_________________

* English

** Portugûes

 
LOG-IN                                 

User


Password




Forgot your password?






ACTIONS ___     ___ _         

Submit Article

Check Manuscript Status

Suscription

Free Sample Issue



STATISTICS ___     ___        

JCR Impact Factor 2013:
0.319

5-Year JCR Impact Factor:

0.334

Issues per year: 10

ISSN 0326 2383 (printed ed.)

ISSN 2362-3853 (on line ed.)
 




© Latin American Journal of Pharmacy 2015 | All rights reserved

Developed by: CAFFINI / COMMUNICATION & DESIGN